Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Testicular Seminoma
Regimen:
VeIP (cisplatin + ifosfamide + vinblastine)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
ESMO.org
Excerpt:
Standard treatment strategies for seminoma: first line…stage IIA…BEP…or EP…
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Management of pure seminoma stages IIA, IIB, IIC and III after chemotherapy…VIP, or VeIP (vinblastine, mesna, ifosfamide, cisplatin) is recommneded...
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login